Please ensure Javascript is enabled for purposes of website accessibility

Why Ambarella, Qiagen, and SmileDirectClub Slumped Today

By Dan Caplinger - Oct 8, 2019 at 4:35PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Even kind words from Wall Street pros aren't always enough to lift a stock.

Wall Street took a hit on Tuesday, with major benchmarks generally seeing losses of 1% to 1.7%. The latest news on the trade front signaled worsening relations between the U.S. and China, and investors seem increasingly uncertain that the two nations will be able to resolve their differences at any point in the near future. That hit some stocks directly, including several Chinese stocks, but others lost ground due to their own individual problems. Ambarella (AMBA 3.14%), Qiagen (QGEN -1.60%), and SmileDirectClub (SDC -6.01%) were among the worst performers. Here's why they did so poorly.

Ambarella takes a hit in the trade war

Shares of Ambarella fell over 9% after the maker of video camera sensor chips became the latest casualty of the trade conflict. Ambarella provides its chips to several Chinese companies, and two major customers, Dahua and Hikvision, were included among the more than two dozen companies that made it onto the U.S. blacklist. Analysts quickly noted that Ambarella might still be able to make shipments through non-U.S. entities, but those following the video chip maker are concerned that taking away key parts of its business at a critical time in the industry could prove damaging to its long-term prospects.

Chip with Ambarella markings on the back.

Image source: Ambarella.

Qiagen reports results, changes its CEO

Qiagen saw its stock drop 21% after several news items called its strategic direction into doubt. The German healthcare specialist said that CEO Peer Schatz will step down after 27 years with the company, with Qiagen naming an interim CEO while it looks for a permanent chief executive. Qiagen also said preliminary third-quarter sales growth would come in around 3%, which was less than the 4% to 5% growth that it had previously expected. Some investors hope that a strategic collaboration with Illumina will help Qiagen gain traction, but others fear that competition in the industry will make it increasingly difficult to pick up steam -- especially without someone permanently at the helm.

SmileDirectClub frowns

Finally, shares of SmileDirectClub sank 16%. The dental alignment specialist has seen wild moves over the past several days, with comments from short-sellers pushing the stock down only to see it recover when analysts at key underwriting banks gave their support for the company's business model. Today, investors seemed more skeptical of that support, especially after SmileDirectClub decided to issue a statement specifically saying that analysts' reports "reinforce the value of our business model, unit economics, and mission to transform smiles through safe, affordable, and consumer-first technology." The company will have to back up its claims with results, and it'll take a while for investors to get a final answer as to whether SmileDirectClub can compete with rivals in its field.

Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Ambarella and Illumina. The Motley Fool recommends Qiagen N.V. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

QIAGEN N.V. Stock Quote
QIAGEN N.V.
QGEN
$47.28 (-1.60%) $0.77
Ambarella, Inc. Stock Quote
Ambarella, Inc.
AMBA
$90.42 (3.14%) $2.75
SmileDirectClub, Inc. Stock Quote
SmileDirectClub, Inc.
SDC
$1.70 (-6.01%) $0.11

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
394%
 
S&P 500 Returns
127%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.